Company News
News
Latest news66
Company News
Meet The Disruptors: Anil Narasimha Of Mekonos On The Five Things You Need To Shake Up Your Industry
"Anytime you want to be a disruptor in a space, you have to start by understanding what the status quo is in that space, because sometimes it can be a moving target. Sometimes if you haven’t defined the status quo properly, you can go down a rabbit hole that you don’t necessarily need to go down." Read post
Company News
Funding Success for Seaweed-Based Bacon Startup
Pioneering the production of seaweed-based bacon alternatives, Berkeley-based Umaro Foods reports a successful second funding round, and is looking to move its products into retail markets. Read post
Company News
Profluent Secures $35M in Additional Funding and Key Industry Experts to Scale Foundational AI Models for Biomedicine and Tackle First Vertical in Gene Editing
“Our research at the forefront of AI has enabled Profluent to create large language models that begin to learn the blueprint of nature,” said Ali Madani, Profluent co-founder and Chief Executive Officer. “We are moving biology from being constrained by what can be discovered in nature to being able to design precisely according to our needs via AI. The science is real and the time is now to proactively create breakthrough medicines that can transform society.” Read post
Company News
Jenny Hamilton, CEO of Stealth Startup, Featured in Story of Jennifer Doudna’s Women in Enterprising Science Incubator
With its second cohort of young women scientists testing their problem-solving skills and entrepreneurial ambitions, the HS Chau Women in Enterprising Science Program within Nobel laureate Jennifer Doudna’s Innovative Genomics Institute is giving rise to a new generation of biotech startups. At the same time, the program is solidifying Doudna’s legacy. Read post
Company News
Umaro Foods Raises $3.8M for Seaweed Bacon, is “Laser Focused on Undercutting Hormel and Smithfield on Cost”
Umaro Foods’ next phase of growth is fueled by an automated, high-throughput manufacturing process that will produce its plant-based bacon product at half the cost of pork bacon. “Scaling up is all about unit economics, and that’s why we used our last round of financing to prepare for high throughput, low capex manufacturing,” said Zotter. Read post
Company News
Dupixent in a Pill? Startup Insamo Will Try To Turn Blockbuster Biologics Into Orals
Berkeley, CA-headquartered Insamo was founded in 2022 by a trio of PhD scientists, who have raised a $12 million seed round that includes investors like venBio and Playground Global, CEO Tim Craven told Endpoints News exclusively. The board includes Playground’s venture partner Matt Hershenson and is chaired by venBio managing partner Corey Goodman. Insamo is developing macrocyclic peptides, which look like ring-shaped mini-proteins. They aim to have the potency of antibody drugs while being small enough to stay orally bioavailable, meaning they could be taken as pills rather than injections or infusions. Read post
Company News
Insamo Pulls $12M Seed Round To Put Peptides Under a Magnifying Glass
Insamo starts by leveraging its AI and ML models to design more than trillions of unique molecules that are all orally bioavailable. Next, the company screens each and every one of the compounds against the target of interest. “It feels like cheating because you get the right answer every time,” Craven said, thanks to Insamo’s one-two punch of at-scale, AI-informed drug design, followed by affinity screenings that look for antibody-like binding. Read post
Company News
Lab-Grown Cells Planted Under Skin Offer Hope for Diabetes
Scientists are developing ways to transplant insulin-producing cells into the forearms of patients with type 1 diabetes. Read post
Company News
How a Promise Sparked Ray CEO Paul Bresge’s Quest to Treat a Blinding Disease
One of his daughters, Tamar, was diagnosed with retinitis pigmentosa in 2010 at the age of 15, when the family was living in Toronto. “We were basically told—in the whole span of . . . maybe two or three minutes—‘You’re going blind, there’s nothing that can be done to save your vision, here is a handbook to the Canadian National Institute for the Blind,’” he said. “That was a real pivotal moment for all of us, particularly her.” Read post
Company News
With Funding in Hand, Tome Biosciences Buys Replace Therapeutics for $185M
Replace’s technology combines the site specificity of CRISPR/Cas9 technology with writing enzyme DNA ligase to manipulate small DNA sequences, a company press release stated, which complements Tome’s large DNA PGI technology. Per terms of the deal, Tome will acquire Replace for $65 million upfront and make other near-term milestone payments for a total deal value of up to $185 million through a mix of stock and cash. As a result, Replace will become a wholly-owned subsidiary of Tome. Read post
Company News
Tome Biosciences Acquires Replace Therapeutics
Replace Therapeutics was founded by serial entrepreneur Shakked Halperin, PhD, whose previous company Rewrite Therapeutics was acquired by Intellia Therapeutics, and is backed by Civilization Ventures. The technology combines the site-specificity of CRISPR/Cas9 with the writing enzyme DNA ligase to precisely manipulate small DNA sequences. Read post
Company NewsArticle
Radar Therapeutics Wins First-Ever Amgen Bakar Labs Diversity, Inclusion & Belonging Award
“We're elated to see Amgen promoting the importance of diversity, inclusion, and belonging at their company and in industry, and honored to have received the award,” says Radar CEO and co-founder Sophia Lugo, a first-generation immigrant from Mexico. Sophia co-founded Radar with CSO Eerik Kaseniit, a Stanford bioengineer originally from Estonia. Read post
Company News
Black Sheep’s Lamb Featured on Guy Fieri’s “Diners, Drive-Ins and Dives”
During the Nic’s On Beverly portion of the show, restaurant owner Nic Adler cooks two recipes: Vegan Lamb Bolognese featuring Black Sheep Foods’ vegan lamb and a Lion’s Mane Asada Detroit-Style Pizza. Read post
Company News
Sampling Human Subsidiary Xeno Wins Entrepreneurial Project of the Year Award from Czech Ministry for Industry and Trade
Xeno Cell Innovations won an award in the "Applications" program for "extraordinary social contribution." Xeno is a subsidiary of Sampling Human, which CEO Daniel Georgiev co-founded in the Czech Republic in 2016. Read post
Company News
Umaro Is on C&E News’ Radar
There’s nothing quite like a crispy piece of bacon. But the pork industry releases more greenhouse gases than the entire country of Germany each year, according to the Food and Agriculture Organization of the United Nations. While some companies make plant-based bacon, the start-up Umaro Foods says existing products lack the key characteristic that makes bacon delicious: crispiness. Read post
Company News